Tus kws kho mob
Upcoming policies effective November 2_ 2020.pdf
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2461 - 2470 ntawm 4139
Tus kws kho mob
Upcoming policies effective November 30_ 2020.pdf
Tus kws kho mob
P76-20 2021 Renewal Changes Summary for Institutional Providers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2020
Tus kws kho mob
2020 October Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2020
Tus kws kho mob
QP81-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Risdiplam PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP79-20 Introducing the Blue Cross Blue Shield System’s New National High-Performance Network
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP64R1-20 Medical Drug Update for New to Market Viltolarsen (Viltepso)
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP80-20 MHCP Pharmacy Benefit Update - AvsolaTM, Ilaris® and PerserisTM
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP78-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa®
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP77-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020